vs
Acadia Healthcare Company, Inc.（ACHC）与柯蒂斯-莱特（CW）财务数据对比。点击上方公司名可切换其他公司
柯蒂斯-莱特的季度营收约是Acadia Healthcare Company, Inc.的1.2倍（$947.0M vs $821.5M），柯蒂斯-莱特净利率更高（14.5% vs -143.3%，领先157.8%），柯蒂斯-莱特同比增速更快（14.9% vs 6.1%），柯蒂斯-莱特自由现金流更多（$315.1M vs $-179.5M），过去两年柯蒂斯-莱特的营收复合增速更高（15.2% vs 3.4%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
柯蒂斯-莱特公司是总部位于美国北卡罗来纳州戴维森的制造与服务提供商，在美国内外均设有工厂及业务网点。公司1929年由柯蒂斯、莱特及多家供应商合并成立，成立之初即为美国最大航空企业，二战期间为美军生产了超14.2万台航空发动机。
ACHC vs CW — 直观对比
营收规模更大
CW
是对方的1.2倍
$821.5M
营收增速更快
CW
高出8.8%
6.1%
净利率更高
CW
高出157.8%
-143.3%
自由现金流更多
CW
多$494.6M
$-179.5M
两年增速更快
CW
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $947.0M |
| 净利润 | $-1.2B | $137.0M |
| 毛利率 | — | 37.5% |
| 营业利润率 | -142.4% | 19.2% |
| 净利率 | -143.3% | 14.5% |
| 营收同比 | 6.1% | 14.9% |
| 净利润同比 | -3710.4% | 16.2% |
| 每股收益（稀释后） | $-12.98 | $3.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCCW
| Q4 25 | $821.5M | $947.0M | ||
| Q3 25 | $851.6M | $869.2M | ||
| Q2 25 | $869.2M | $876.6M | ||
| Q1 25 | $770.5M | $805.6M | ||
| Q4 24 | $774.2M | $824.3M | ||
| Q3 24 | $815.6M | $798.9M | ||
| Q2 24 | $796.0M | $784.8M | ||
| Q1 24 | $768.1M | $713.2M |
净利润ACHCCW
| Q4 25 | $-1.2B | $137.0M | ||
| Q3 25 | $36.2M | $124.8M | ||
| Q2 25 | $30.1M | $121.1M | ||
| Q1 25 | $8.4M | $101.3M | ||
| Q4 24 | $32.6M | $117.9M | ||
| Q3 24 | $68.1M | $111.2M | ||
| Q2 24 | $78.5M | $99.5M | ||
| Q1 24 | $76.4M | $76.5M |
毛利率ACHCCW
| Q4 25 | — | 37.5% | ||
| Q3 25 | — | 37.7% | ||
| Q2 25 | — | 37.2% | ||
| Q1 25 | — | 36.3% | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 37.3% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 35.6% |
营业利润率ACHCCW
| Q4 25 | -142.4% | 19.2% | ||
| Q3 25 | 4.7% | 19.1% | ||
| Q2 25 | 5.8% | 17.8% | ||
| Q1 25 | 1.7% | 16.0% | ||
| Q4 24 | 4.9% | 18.8% | ||
| Q3 24 | 12.1% | 18.1% | ||
| Q2 24 | 13.4% | 16.4% | ||
| Q1 24 | 12.9% | 14.0% |
净利率ACHCCW
| Q4 25 | -143.3% | 14.5% | ||
| Q3 25 | 4.3% | 14.4% | ||
| Q2 25 | 3.5% | 13.8% | ||
| Q1 25 | 1.1% | 12.6% | ||
| Q4 24 | 4.2% | 14.3% | ||
| Q3 24 | 8.4% | 13.9% | ||
| Q2 24 | 9.9% | 12.7% | ||
| Q1 24 | 9.9% | 10.7% |
每股收益（稀释后）ACHCCW
| Q4 25 | $-12.98 | $3.69 | ||
| Q3 25 | $0.40 | $3.31 | ||
| Q2 25 | $0.33 | $3.19 | ||
| Q1 25 | $0.09 | $2.68 | ||
| Q4 24 | $0.36 | $3.09 | ||
| Q3 24 | $0.74 | $2.89 | ||
| Q2 24 | $0.85 | $2.58 | ||
| Q1 24 | $0.83 | $1.99 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | — |
| 总债务越低越好 | $2.5B | $957.9M |
| 股东权益账面价值 | $1.9B | $2.5B |
| 总资产 | $5.5B | $5.2B |
| 负债/权益比越低杠杆越低 | 1.28× | 0.38× |
8季度趋势，按日历期对齐
现金及短期投资ACHCCW
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | $226.5M | ||
| Q4 24 | $76.3M | $385.0M | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — | ||
| Q1 24 | $77.3M | $338.0M |
总债务ACHCCW
| Q4 25 | $2.5B | $957.9M | ||
| Q3 25 | $2.3B | $968.6M | ||
| Q2 25 | $2.3B | $958.4M | ||
| Q1 25 | $2.2B | $958.6M | ||
| Q4 24 | $2.0B | $1.0B | ||
| Q3 24 | $1.9B | $1.0B | ||
| Q2 24 | $1.8B | $1.0B | ||
| Q1 24 | $1.9B | $1.1B |
股东权益ACHCCW
| Q4 25 | $1.9B | $2.5B | ||
| Q3 25 | $3.1B | $2.5B | ||
| Q2 25 | $3.1B | $2.7B | ||
| Q1 25 | $3.0B | $2.6B | ||
| Q4 24 | $3.1B | $2.4B | ||
| Q3 24 | $3.0B | $2.5B | ||
| Q2 24 | $3.0B | $2.5B | ||
| Q1 24 | $2.9B | $2.4B |
总资产ACHCCW
| Q4 25 | $5.5B | $5.2B | ||
| Q3 25 | $6.4B | $5.1B | ||
| Q2 25 | $6.3B | $5.2B | ||
| Q1 25 | $6.1B | $5.0B | ||
| Q4 24 | $6.0B | $5.0B | ||
| Q3 24 | $5.9B | $4.9B | ||
| Q2 24 | $5.7B | $4.7B | ||
| Q1 24 | $5.5B | $4.6B |
负债/权益比ACHCCW
| Q4 25 | 1.28× | 0.38× | ||
| Q3 25 | 0.74× | 0.38× | ||
| Q2 25 | 0.74× | 0.35× | ||
| Q1 25 | 0.72× | 0.37× | ||
| Q4 24 | 0.64× | 0.43× | ||
| Q3 24 | 0.62× | 0.42× | ||
| Q2 24 | 0.62× | 0.43× | ||
| Q1 24 | 0.65× | 0.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $352.7M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $315.1M |
| 自由现金流率自由现金流/营收 | -21.8% | 33.3% |
| 资本支出强度资本支出/营收 | 11.3% | 4.0% |
| 现金转化率经营现金流/净利润 | — | 2.57× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $553.7M |
8季度趋势，按日历期对齐
经营现金流ACHCCW
| Q4 25 | $-86.3M | $352.7M | ||
| Q3 25 | $73.2M | $192.8M | ||
| Q2 25 | $133.5M | $136.6M | ||
| Q1 25 | $11.5M | $-38.8M | ||
| Q4 24 | $116.7M | $301.3M | ||
| Q3 24 | $163.1M | $177.3M | ||
| Q2 24 | $171.1M | $111.3M | ||
| Q1 24 | $-321.3M | $-45.6M |
自由现金流ACHCCW
| Q4 25 | $-179.5M | $315.1M | ||
| Q3 25 | $-63.0M | $175.9M | ||
| Q2 25 | $-34.2M | $117.2M | ||
| Q1 25 | $-163.2M | $-54.5M | ||
| Q4 24 | $-86.8M | $278.0M | ||
| Q3 24 | $-27.1M | $162.7M | ||
| Q2 24 | $16.9M | $100.3M | ||
| Q1 24 | $-463.7M | $-57.7M |
自由现金流率ACHCCW
| Q4 25 | -21.8% | 33.3% | ||
| Q3 25 | -7.4% | 20.2% | ||
| Q2 25 | -3.9% | 13.4% | ||
| Q1 25 | -21.2% | -6.8% | ||
| Q4 24 | -11.2% | 33.7% | ||
| Q3 24 | -3.3% | 20.4% | ||
| Q2 24 | 2.1% | 12.8% | ||
| Q1 24 | -60.4% | -8.1% |
资本支出强度ACHCCW
| Q4 25 | 11.3% | 4.0% | ||
| Q3 25 | 16.0% | 1.9% | ||
| Q2 25 | 19.3% | 2.2% | ||
| Q1 25 | 22.7% | 2.0% | ||
| Q4 24 | 26.3% | 2.8% | ||
| Q3 24 | 23.3% | 1.8% | ||
| Q2 24 | 19.4% | 1.4% | ||
| Q1 24 | 18.5% | 1.7% |
现金转化率ACHCCW
| Q4 25 | — | 2.57× | ||
| Q3 25 | 2.02× | 1.54× | ||
| Q2 25 | 4.43× | 1.13× | ||
| Q1 25 | 1.37× | -0.38× | ||
| Q4 24 | 3.58× | 2.56× | ||
| Q3 24 | 2.39× | 1.59× | ||
| Q2 24 | 2.18× | 1.12× | ||
| Q1 24 | -4.21× | -0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
CW
| Naval Power | $417.4M | 44% |
| Defense Electronics | $268.3M | 28% |
| Aerospace Industrial | $262.4M | 28% |
